Latest News
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024
SHANGHAI, May 24, 2024 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech developing innovative Tumor-Infiltrating Lymphocyte (TIL) therapies for cancers, announced latest clinical research results on GC203 (a novel non-viral vector gene-modif...
Tyfon and Global Technology Acquisition Corp. I Announce Public Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination
• Transaction expected to close in the second half of 2024 ZEPHYR COVE, Nev. and SUZHOU, China, May 24, 2024 /PRNewswire/ -- Global Technology Acquisition Corp. I (NASDAQ: GTAC) ("GTAC"), a special purpose acquisition company, and Tyfon Culture Holdings Limited ("Tyfon"), a well-recogniz...
XCMG Machinery Amplifies Presence in Latin America with More Tailor-Made Machines Launched
SAO PAULO, May 24, 2024 /PRNewswire/ -- In a significant move to strengthen its foothold in the Latin American market,XCMG Machinery ("XCMG", SHE:000425) has ramped up its operations, marking the 50th anniversary of the establishment of diplomatic relations betweenChina and Brazil. The company's ...
Rokid AR Lite: The first AR glasses powered by Snapdragon® 6 Gen 1 mobile platform
REDWOOD CITY, Calif., May 24, 2024 /PRNewswire/ -- Rokid
Air Premia, Celebrates the First Anniversary of Its New York Route with Exceptional Performance
* In its first year of service, Air Premia's Incheon-New York route has quickly established itself as a preferred choice for travelers. To celebrate this milestone, Air Premia is offering a limited time special fares and additional flights. NEW YORK, May 24, 2024 /PRNewswire/ -- Hybrid airline ...
K-Pet develops disease prevention solutions to extend the healthy life of pets
SEOUL, South Korea, May 24, 2024 /PRNewswire/ -- On the 23rd, K-PET
CNFinance to Hold Annual General Meeting on June 7, 2024
GUANGZHOU, China, May 24, 2024 /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced that it will hold its annual general meeting of shareholders (the "AGM") at 44/F, Tower G, No. 16 Zhujiang Do...
Atour Unveils Sustainability Records in 2023 With Milestone ESG Report
SHANGHAI, May 24, 2024 /PRNewswire/ -- May 23, Atour Lifestyle Holdings Limited (NASDAQ: ATAT), a leading hospitality and lifestyle company inChina, has released its inaugural Environmental, Social, and Governance (ESG) report for 2023. The report underscores the company's sustainability efforts...
36Kr Hosts "AI Partner • Advanced Productivity" Conference
BEIJING, May 24, 2024 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants inChina, today hosted its "AI Partner • Advanced Productivity" Conference inBeijing, exploring AI technology...
New Oriental Extends Share Repurchase Program
BEIJING, May 24, 2024 /PRNewswire/ -- New Oriental Education & Technology Group Inc. ("New Oriental" or the "Company") (NYSE: EDU and SEHK: 9901), a provider of private educational services inChina, today announced that its board of directors has authorized the Company to extend its share repurch...
Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and Orally Bioavailable KRAS G12D Inhibitor
SHANGHAI, May 24, 2024 /PRNewswire/ -- Tyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the first patient had been dosed in the Phase 1/2 trial of TSN1611 for the treatment of KRAS G12D mutant solid...
Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
* Anittumor efficacy of sunvozertinib was observed in patients regardless of baseline EGFR exon20ins status in plasma ctDNA. * Sunvozertinib could effectively clear EGFR exon20ins in plasma ctDNA, confirming its direct effect on EGFR pathway. * The resistance to sunvozertinib could be thro...
Newrizon Partnered With Al Yemni Group, Bringing Its Futuristic EV Truck In GCC Region
RIYADH, Saudi Arabia , May 24, 2024 /PRNewswire/ -- Recently in Riyadh, Newrizon , a startup dedicated in electrifying and revolutionizing urban delivery vehicles,signed dealership agreement and intent purchase order with Al Yemni Group, authorizing it as Newrizon's exclusive dealer in the GCC reg...
HoneyNaps secures a $11.6 million Series B investment, becoming the No. 1 ranked A.I Sleep Technology Company
HoneyNaps secures $11.6 million in series B funding, propelling its entry into the American medical market. BOSTON, May 24, 2024 /PRNewswire/ -- HoneyNaps, an industry-leading South Korean company in artificial intelligence (AI) sleep data analysis, announced on the 7th that it has closed its se...
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates
SUZHOU, China and ROCKVILLE, Md., May 23, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its four abstracts selected for presentations a...
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024
Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression, including in patients with PD-L1 CPS<5. PRINCETON, N.J. and SUZHOU, China, May 23, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a global clinical stage biopharm...
Infobird Co., Ltd Receives Notification from Nasdaq for Failure to Timely File Form 20-F
HONG KONG, May 23, 2024 /PRNewswire/ -- Infobird Co., Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"), a software-as-a-service provider of AI-powered customer engagement solutions inChina, today reports that as of May 16, 2024, it is delinquent in filing its annual report on Form 20-F for the fi...
SEMIFIVE Signs MOU with Atron Technologies to Collaborate on Semiconductor Design
Expected to expand global business in the Chinese market SEOUL, South Korea, May 23, 2024 /PRNewswire/ -- SEMIFIVE, a leading design solution provider and pioneer of platform-based custom silicon solutions, has announced its agreement of MOU withChina-based Atron Technologies, on May 23, 2024. T...
Emeren Announces First Quarter 2024 Financial Results
STAMFORD, Conn., May 23, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the
"Company") (www.emeren.com
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024
SUZHOU, China, May 23, 2024 /PRNewswire/ -- On May 10, 2024, Cure Genetics announced the safety and efficacy data of their CAR-NKT product, CGC729, for patients with relapsed and refractory metastatic renal cell carcinoma (R/R mRCC) in an oral presentation at the 27th Annual Meeting of the Americ...
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1187 media titles]
2026-11-13 22:11The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1173 media titles]
2026-11-14 13:23Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1172 media titles]
2026-11-12 23:00Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1155 media titles]
2026-11-11 22:00Kraft Heinz Casts Spotlight on its NYSE Listing: NYSE Content Update
[Picked up by 1088 media titles]
2026-11-12 21:55